Systematic review with meta‐analysis: the efficacy and safety of CT‐P13, a biosimilar of anti‐tumour necrosis factor‐α agent (infliximab), in inflammatory bowel diseases
Y. Komaki; A. Yamada; F. Komaki; D. Micic; A. Ido; A. Sakuraba
Author Information: Section of Gastroenterology
|Checking for direct PDF access through Ovid|
Abstract unavailable for this article.